Monthly Archives: July 2023

//July

Pay uplift for public sector workforce

Responding to the recent announcement of the funding uplift to the GP contract and 6% pay rise for the public sector workforce (inclusive of eligible junior doctors, consultants, dentists, and senior NHS staff), we have released the following statement. Chief Executive Janet Morrison, said: “The public sector workforce pay rise will be welcome news for [...]

The post Pay uplift for public sector workforce appeared first on Community Pharmacy England.

By |July 14th, 2023|Lexpos News|Comments Off on Pay uplift for public sector workforce

UK Covid-19 Inquiry: Every Story Matters

The UK Covid-19 Inquiry is seeking input from pharmacists nationwide, to share your pandemic experiences through the Every Story Matters initiative. Recognising the crucial role played by community pharmacy during the pandemic, the Inquiry is keen to gather the unique experiences and stories from pharmacists and their teams. This campaign provides people with a chance [...]

The post UK Covid-19 Inquiry: Every Story Matters appeared first on Community Pharmacy England.

By |July 13th, 2023|Lexpos News|Comments Off on UK Covid-19 Inquiry: Every Story Matters

MHRA Class 2 Medicines Recall: Sabril 500 mg film-coated tablets & 500 mg granules for oral solution (Aventis Pharma Limited (t/a Sanofi))

Drug alert number: EL (23)A/25 Date issued: 10 July 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Sabril 500 mg film-coated tablets & Sabril 500 mg granules for oral solution (Aventis Pharma Limited (t/a Sanofi)) Product name Sabril 500 mg film-coated tablets, PL 04425/0171 Batch number [...]

The post MHRA Class 2 Medicines Recall: Sabril 500 mg film-coated tablets & 500 mg granules for oral solution (Aventis Pharma Limited (t/a Sanofi)) appeared first on Community Pharmacy England.

By |July 13th, 2023|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Sabril 500 mg film-coated tablets & 500 mg granules for oral solution (Aventis Pharma Limited (t/a Sanofi))

MHRA Class 2 Medicines Recall: Sabril 500mg film-coated tablets and 500mg granules for oral solution (Aventis Pharma Limited (t/a Sanofi)

Date issued: 13 July 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Sabril 500 mg film-coated tablets & Sabril 500 mg granules for oral solution. Sabril 500 mg film-coated tablets Pl 04425/0171 Batch number Expiry date Pack size First distributed 2989A April 2025 100 02/08/22 2988D [...]

The post MHRA Class 2 Medicines Recall: Sabril 500mg film-coated tablets and 500mg granules for oral solution (Aventis Pharma Limited (t/a Sanofi) appeared first on Community Pharmacy England.

By |July 13th, 2023|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Sabril 500mg film-coated tablets and 500mg granules for oral solution (Aventis Pharma Limited (t/a Sanofi)

July 2023 Price Concessions 1st Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners (our members), the Department has today (13/07/2023) announced the following initial list of price concessions for July 2023: Drug Pack size Price concession Amisulpride 100mg tablets 60 £18.15 Atorvastatin 10mg tablets 28 [...]

The post July 2023 Price Concessions 1st Update appeared first on Community Pharmacy England.

By |July 13th, 2023|Lexpos News|Comments Off on July 2023 Price Concessions 1st Update